Oxidative stress, dietary supplementation and hypertensive disorders in pregnancy: a review

Authors

DOI:

https://doi.org/10.2478/AMB-2025-0067

Keywords:

preeclampsia, intrauterine growth restriction, gestational diabetes mellitus, recurrent pregnancy loss, luteolysis

Abstract

Objective. To provide an understanding of the effects of oxidative stress and hypertensive disorders during pregnancy and the significance of dietary supplementation in addressing the related adverse outcomes and complications. Methodology. The review methodology was designed to provide a flexible but a comprehensive overview of pregnancy in terms of oxidative stress, hypertensive disorders and dietary supplementation through identification of applicable and relevant literature that was based on an inclusion and exclusion criteria that followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) framework for systematic reviews. Findings. Hypertensive disorders are a primary risk factor for adverse pregnancy outcomes, accounting for 14 percent of maternal mortality and occurring in up to 10 percent of all pregnancies. The mechanisms leading to oxidative stress during pregnancy can cause the excessive generation of highly reactive and unstable reactive oxygen species radicals, which can directly disrupt gestational processes such as oocyte maturation, luteolysis, and embryo implantation. Excessive production of reactive oxygen species can directly interfere with the placental membrane, which can disrupt the exchange of nutrients and oxygen between the mother and fetus, leading to poor embryo development and pregnancy complications. There is a direct association between imbalanced serum nutrient levels and adverse health outcomes during pregnancy, such as inflammation and dyslipidemia. Conclusion. The adverse pregnancy outcomes associated with genetic and biological risk factors, such as oxidative stress and hypertensive disorders, are preventable and manageable through proper hygienic conditions, appropriate lifestyle choices, and pharmacological and dietary interventions.

References

Kirovakov Z, Konova E, Hinkova N, Markova S. Algorithm for Prevention of Recurrent Pregnancy Loss and Adverse Pregnancy Outcomes in Patient with Inherited Thrombophilia. International Journal of Medical Science and Clinical Invention [Internet]. 2024 Aug 21;11(08):7226–35. Available from: https://doi.org/10.18535/ijmsci/v11i8.02

Man AWC, Zhou Y, Xia N, Li H. Dietary supplements and vascular function in hypertensive disorders of pregnancy. Pflugers Arch. 2023 Jul;475(7):889-905. doi: 10.1007/s00424-023-02810-2

Gliozheni O, Gliozheni E. Some solutions to reduce maternal mortality. Donald School Journal of Ultrasound in Obstetrics & Gynecology [Internet]. 2018 Dec 1;14(1):56–60. Available from: https://doi.org/10.5005/jp-journals-10009-1615.

Khedagi AM, Bello NA. Hypertensive Disorders of Pregnancy. Cardiol Clin. 2021 Feb;39(1):77-90. doi: 10.1016/j.ccl.2020.09.005.

Wang Z, Chen J, Zhu L, Jiao S, Chen Y, Sun Y. Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study. BMC Cardiovasc Disord. 2023 Oct 31;23(1):529. doi: 10.1186/s12872-023-03567-3.

Poon LC, Nguyen-Hoang L, Smith GN, et al. Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO Best Practice Advice. International Journal of Gynecology & Obstetrics. 2023 Jan 1;160(S1):22–34. doi.org/10.1002/ijgo.14540

T. Hussain et al., “The Role of Oxidative Stress and Antioxidant Balance in Pregnancy,” Mediators of Inflammation, vol. 2021, pp. 1–11, Sep. 2021, doi: 10.1155/2021/9962860.

Chiarello DI, Abad C, Rojas D, Toledo F, Vázquez CM, Mate A, Sobrevia L, Marín R. Oxidative stress: Normal pregnancy versus preeclampsia. Biochim Biophys Acta Mol Basis Dis. 2020 Feb 1;1866(2):165354. doi: 10.1016/j.bbadis.2018.12.005.

Duhig K, Chappell LC, Shennan AH. Oxidative stress in pregnancy and reproduction. Obstet Med. 2016 Sep;9(3):113-6. doi: 10.1177/1753495X16648495.

Pham C, Thomson S, Chin ST, et al; Barwon Infant Study Investigator Group. Maternal oxidative stress during pregnancy associated with emotional and behavioural problems in early childhood: implications for foetal programming. Mol Psychiatry. 2023 Sep;28(9):3760-3768. doi: 10.1038/s41380-023-02284-9.

Grzeszczak K, Łanocha-Arendarczyk N, Malinowski W, et al. Oxidative Stress in Pregnancy. Biomolecules. 2023 Dec 9;13(12):1768. doi: 10.3390/biom13121768.

Parikh NI, Gonzalez JM, Anderson CAM, et al; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021 May 4;143(18):e902-e916. doi: 10.1161/CIR.0000000000000961.

Phoswa WN, Khaliq OP. The Role of Oxidative Stress in Hypertensive Disorders of Pregnancy (Preeclampsia, Gestational Hypertension) and Metabolic Disorder of Pregnancy (Gestational Diabetes Mellitus). Oxid Med Cell Longev. 2021 May 31;2021:5581570. doi: 10.1155/2021/5581570.

Kaltsas A. et al., The Silent Threat to Women’s Fertility: Uncovering the Devastating Effects of Oxidative Stress. Antioxidants, 2023;12(8),1490. doi: 10.3390/antiox12081490.

Guerby P, Tasta O, Swiader A, et al. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2021 Apr;40:101861. doi: 10.1016/j.redox.2021.101861.

Garcia V, Sessa WC. Endothelial NOS: perspective and recent developments. Br J Pharmacol. 2019 Jan;176(2):189-196. doi: 10.1111/bph.14522.

Lyu Y, Wang G, Sun Z, et al. The association of maternal fat-soluble antioxidants in early pregnancy with gestational diabetes mellitus: a prospective cohort study. Nutr Diabetes. 2022 Dec 9;12(1):49. doi: 10.1038/s41387-022-00227-x.

Saucedo R, Ortega-Camarillo C, Ferreira-Hermosillo A, et al. Role of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus. Antioxidants (Basel). 2023 Sep 29;12(10):1812. doi: 10.3390/antiox12101812.

Daneshzad E, Tehrani H, Bellissimo N, Azadbakht L. Dietary Total Antioxidant Capacity and Gestational Diabetes Mellitus: A Case-Control Study. Oxid Med Cell Longev. 2020 Oct 8;2020:5471316. doi: 10.1155/2020/5471316.

Giorgione V, O’Driscoll J, Coutinho CM, et al. Peripartum echocardiographic changes in women with hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol. 2022 Mar;59(3):365-370. doi: 10.1002/uog.23745.

Mulder EG, de Haas S, Mohseni Z, et al. Cardiac output and peripheral vascular resistance during normotensive and hypertensive pregnancy – a systematic review and meta-analysis. BJOG. 2022 Apr;129(5):696-707. doi: 10.1111/1471-0528.16678

Ling HZ, Guy GP, Bisquera A, et al. Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial. Ultrasound Obstet Gynecol. 2019 Jul;54(1):51-57. doi: 10.1002/uog.20125.

Reddy M, Wright L, Rolnik DL, et al. Evaluation of Cardiac Function in Women With a History of Preeclampsia: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2019 Nov 19;8(22):e013545. doi: 10.1161/JAHA.119.013545.

Countouris ME, Villanueva FS, Berlacher KL, et al. M. Association of Hypertensive Disorders of Pregnancy With Left Ventricular Remodeling Later in Life. J Am Coll Cardiol. 2021 Mar 2;77(8):1057-1068. doi: 10.1016/j.jacc.2020.12.051.

Eghan P, Folson AA, Donkor A, et al. Relationship between hypertensive disorders of pregnancy (HDP) and cardiac remodeling during pregnancy: Systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024 Jul;298:108-115. doi: 10.1016/j.ejogrb.2024.05.003.

Garcia-Gonzalez C, Nunez E, Zhang H, et al. Maternal and Offspring Cardiovascular Function following Pregnancy with Hypertensive Disorder. Diagnostics (Basel). 2023 Jun 8;13(12):2007. doi: 10.3390/diagnostics13122007.

Giorgione V, Ridder A, Kalafat E, et al. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre-eclampsia: a systematic review and meta-analysis. BJOG. 2021 Feb;128(3):495-503. doi: 10.1111/1471-0528.16545. Epub 2020 Oct 21.

Malek AM, Wilson DA, Turan TN, et al. Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension. J Am Heart Assoc. 2021 Feb;10(5):e018155. doi: 10.1161/JAHA.120.018155.

Dall’Asta A, D’Antonio F, Saccone G, et al. Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021 May;57(5):698-709. doi: 10.1002/uog.22107.

Zhao G, Bhatia D, Jung F, Lipscombe L. Risk of type 2 diabetes mellitus in women with prior hypertensive disorders of pregnancy: a systematic review and meta-analysis. Diabetologia. 2021 Mar;64(3):491-503. doi: 10.1007/s00125-020-05343-w.

Marshall NE, Abrams B, Barbour LA, et al. The importance of nutrition in pregnancy and lactation: lifelong consequences. Am J Obstet Gynecol. 2022 May;226(5):607-632. doi: 10.1016/j.ajog.2021.12.035.

Parrettini S, Caroli A, Torlone E. Nutrition and Metabolic Adaptations in Physiological and Complicated Pregnancy: Focus on Obesity and Gestational Diabetes. Front Endocrinol (Lausanne). 2020 Nov 30;11:611929. doi: 10.3389/fendo.2020.611929.

Qin Y, Xie L. Nutrition and Supplements during Pregnancy: A Vital Component in Building the Health and Well-Being of Both the Mother and the Developing Baby. Nutrients. 2023 Jul 31;15(15):3395. doi: 10.3390/nu15153395.

Ciulei MA, Smith ER, Perumal N, et al. Nutritious Supplemental Foods for Pregnant Women from Food Insecure Settings: Types, Nutritional Composition, and Relationships to Health Outcomes. Curr Dev Nutr. 2023 Apr 28;7(6):100094. doi: 10.1016/j.cdnut.2023.100094.

Koivuniemi E, Hart K, Mazanowska N, et al. Food Supplement Use Differs from the Recommendations in Pregnant Women: A Multinational Survey. Nutrients. 2022 Jul 15;14(14):2909. doi: 10.3390/nu14142909.

Dingena CF, Arofikina D, Campbell MD, et al. Nutritional and Exercise-Focused Lifestyle Interventions and Glycemic Control in Women with Diabetes in Pregnancy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients. 2023 Jan 9;15(2):323. doi: 10.3390/nu15020323.

Broś-Konopielko M, Białek A, Johne M, Czajkowski K. Increased LC PUFA Levels in the Serum of Pregnant Women and Their Children as a Result of Dietary Supplementation with ‘Omega’ Fatty Acids. Nutrients. 2023 Jan 2;15(1):231. doi: 10.3390/nu15010231.

Peng H, Xu H, Wu J, et al. Maternal high-fat diet disrupted one-carbon metabolism in offspring, contributing to nonalcoholic fatty liver disease. Liver Int. 2021 Jun;41(6):1305-1319. doi: 10.1111/liv.14811.

Lassi ZS, Padhani ZA, Rabbani A, et al. Effects of nutritional interventions during pregnancy on birth, child health and development outcomes: A systematic review of evidence from low- and middle-income countries. Campbell Syst Rev. 2021 Jun 21;17(2):e1150. doi: 10.1002/cl2.1150.

Weckman AM, McDonald CR, Baxter JB, et al. Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings. Adv Nutr. 2019 Sep 1;10(5):765-777. doi: 10.1093/advances/nmz015.

Ortiz-Cerda T, Mosso C, Alcudia A, et al. Pathophysiology of Preeclampsia and L-Arginine/L-Citrulline Supplementation as a Potential Strategy to Improve Birth Outcomes. Adv Exp Med Biol. 2023;1428:127-148. doi: 10.1007/978-3-031-32554-0_6.

Man AWC, Zhou Y, Lam UDP, et al. l-Citrulline ameliorates pathophysiology in a rat model of superimposed preeclampsia. Br J Pharmacol. 2022 Jun;179(12):3007-3023. doi: 10.1111/bph.15783.

Downloads

Published

02.09.2025

Issue

Section

SCIENTIFIC REVIEW

How to Cite

Kirovakov, Z. (2025). Oxidative stress, dietary supplementation and hypertensive disorders in pregnancy: a review. Acta Medica Bulgarica, 52(3), 95-100. https://doi.org/10.2478/AMB-2025-0067